Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?

被引：1
|
作者：
Saydan, Betuel [1 ]
Ozmen, Deniz [2 ]
Eskazan, Ahmet Emre [2 ]
机构：
[1] Ankara Univ, Fac Med, Ankara, Turkiye
[2] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Internal Med, Div Hematol, Istanbul, Turkiye
来源：
EXPERT REVIEW OF HEMATOLOGY | 2024年 / 17卷 / 07期
关键词：
Chronic myeloid leukemia; CML; dasatinib; low-dose; 50; mg; CHRONIC LYMPHOCYTIC-LEUKEMIA; DECISION-SUPPORT-SYSTEM; SURVIVAL; CLL; INCORPORATE; PREFERENCES; POPULATION; GUIDELINES; IBRUTINIB; LYMPHOMA;
D O I：
10.1080/17474086.2024.2370556
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：275 / 277
页数：3
相关论文
共 50 条
  • [31] Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis
    Iriyama, Noriyoshi
    Sugimoto, Kei-Ji
    Sato, Eriko
    Takaku, Tomoiku
    Tokuhira, Michihide
    Nakazato, Tomonori
    Ishikawa, Maho
    Fujita, Hiroyuki
    Fujioka, Isao
    Kimura, Yuta
    Asou, Norio
    Kizaki, Masahiro
    Komatsu, Norio
    Hatta, Yoshihiro
    Kawaguchi, Tatsuya
    MEDICAL ONCOLOGY, 2018, 35 (11)
  • [32] CORRELATION OF DASATINIB PHARMACOKINETICS WITH CLINICAL RESPONSE AND ADVERSE EVENTS IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA CHRONIC PHASE
    Mita, A.
    Miura, M.
    Niioka, T.
    Abumiya, M.
    Kobayasi, T.
    Takahshi, S.
    Kameoka, Y.
    Yoshioka, T.
    Takahashi, N.
    HAEMATOLOGICA, 2015, 100 : 694 - 694
  • [33] Effect of Dose Modifications on 5-Year Efficacy of Dasatinib and Imatinib in Newly Diagnosed Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) From DASISION
    Cortes, Jorge E.
    Hochhaus, Andreas
    Kantarjian, Hagop
    Guilhot, Francois
    Kota, Vamsi
    Hughes, Timothy P.
    Shelat, Suresh
    Sy, Oumar
    Jabbour, Elias
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S308 - S309
  • [34] Optimal initial therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phase
    Atallah, Ehab
    Cortes, Jorge
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (02) : 138 - 144
  • [35] Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007
    Mughal, Tariq
    Goldman, John M.
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S95 - S101
  • [36] The current role of high-dose imatinib in chronic myeloid leukemia patients, newly diagnosed or resistant to standard dose
    Breccia, Massimo
    Alimena, Giuliana
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (13) : 2075 - 2087
  • [37] 5-YEAR EFFICACY OF DASATINIB AND IMATINIB IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH DOSE MODIFICATIONS FROM DASISION
    Hochhaus, A.
    Jabbour, E.
    Kantarjian, H.
    Guilhot, F.
    Kota, V.
    Hughes, T. P.
    Shelat, S.
    Li, L.
    Cortes, J. E.
    HAEMATOLOGICA, 2017, 102 : 433 - 433
  • [38] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Masayuki Hino
    Itaru Matsumura
    Shin Fujisawa
    Kenichi Ishizawa
    Takaaki Ono
    Emiko Sakaida
    Naohiro Sekiguchi
    Yusuke Tanetsugu
    Kei Fukuhara
    Masayuki Ohkura
    Yuichiro Koide
    Naoto Takahashi
    International Journal of Hematology, 2020, 112 : 24 - 32
  • [39] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Hino, Masayuki
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Takahashi, Naoto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 24 - 32
  • [40] Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Takahashi, Naoto
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Hino, Masayuki
    BLOOD, 2019, 134
12345